THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Completed

Conditions: Type 2 Diabetes Mellitus

First Posted Date: 2018-08-27

Last Posted Date: 2020-09-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 48262

Registration Number: NCT03648424

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Pharmacological Activation of HMN for OSA

Phase 1

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Drug: LTM1201LN
Drug: LTM1201LD
Drug: Placebo oral capsule
Drug: LTM1201L
Drug: LTM1201LB

First Posted Date: 2018-08-21

Last Posted Date: 2020-02-24

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 6

Registration Number: NCT03640052

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Sleep Disorders Research Program Brigham and Women's Hospital, Boston, Massachusetts, United States

A Positive Psychology Intervention for Patients With Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Positive Psychology

First Posted Date: 2018-08-20

Last Posted Date: 2021-08-16

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 30

Registration Number: NCT03637699

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: SGLT2
Drug: Metformin

First Posted Date: 2018-08-13

Last Posted Date: 2019-08-13

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 20000

Registration Number: NCT03627039

Locations: 🇺🇸
Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, Massachusetts, United States

Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

Early Phase 1

Withdrawn

Conditions: Hypersomnia
Narcolepsy
Traumatic Brain Injury

Interventions: Drug: Sodium Oxybate Oral Solution [Xyrem]

First Posted Date: 2018-08-13

Last Posted Date: 2021-03-04

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT03626727

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Image Guided VATS vs. VATS Resection

Not Applicable

Recruiting

Conditions: Lung Cancer

Interventions: Device: Image guided Video-Assisted Thoracic Surgery (VATS) resection
Procedure: Video-Assisted Thoracic Surgery

First Posted Date: 2018-08-09

Last Posted Date: 2023-02-08

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 200

Registration Number: NCT03623958

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Virtual Visits at Brigham and Women's Hospital

Not Applicable

Terminated

Conditions: Diabetes Mellitus
Stroke
BPH
Heart Failure
Hypertension
Hyperlipidemia

Interventions: Other: Virtual Visit

First Posted Date: 2018-07-19

Last Posted Date: 2021-09-22

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 77

Registration Number: NCT03592355

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

Phase 4

Active, not recruiting

Conditions: Postpartum Hemorrhage
Uterine Atony

Interventions: Drug: 15-methyl prostaglandin F2α
Drug: Methylergonovine Maleate

First Posted Date: 2018-07-12

Last Posted Date: 2022-05-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 100

Registration Number: NCT03584854

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes

Phase 2

Terminated

Conditions: Wound of Skin
Wound Heal
Full Thickness Skin Graft Healing
Surgical Wound

Interventions: Other: Vaseline dressing
Drug: 0.25% timolol gel with full-thickness skin grafts

First Posted Date: 2018-07-06

Last Posted Date: 2022-01-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10

Registration Number: NCT03579160

Locations: 🇺🇸
Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital, Boston, Massachusetts, United States

Multimodality Intervention for Function and Metabolism in SCI

Phase 2

Active, not recruiting

Conditions: Spinal Cord Injuries

Interventions: Drug: Testosterone Undecanoate
Behavioral: hybrid exercise

First Posted Date: 2018-07-03

Last Posted Date: 2025-05-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 84

Registration Number: NCT03576001

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy